These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine). Lefrancier P; Derrien M; Lederman I; Nief F; Choay J; Lederer E Int J Pept Protein Res; 1978 Apr; 11(4):289-96. PubMed ID: 669885 [TBL] [Abstract][Full Text] [Related]
24. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice. Ishihara C; Yamamoto K; Hamada N; Azuma I Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of fluorescent muramyl dipeptide congeners. 2. Hiebert CK; Kopp WC; Richerson HB; Barfknecht CF J Med Chem; 1988 Oct; 31(10):2022-4. PubMed ID: 3172138 [TBL] [Abstract][Full Text] [Related]
26. Methyl beta-glycosides of N-acetyl-6-O-(omega-aminoacyl)muramyl-L-alanyl-D-isoglutamines, and their conjugates with meningococcal group C polysaccharide. Ponpipom MM; Rupprecht KM Carbohydr Res; 1983 Feb; 113(1):45-56. PubMed ID: 6839311 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin. Ogawa T; Kotani S; Shimauchi H Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372 [TBL] [Abstract][Full Text] [Related]
28. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs. Saiki I; Tanio Y; Yamawaki M; Uemiya M; Kobayashi S; Fukuda T; Yukimasa H; Yamamura Y; Azuma I Infect Immun; 1981 Jan; 31(1):114-21. PubMed ID: 6971259 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of neo-glycosylated L-alanyl-D-isoglutamine derivatives as potential immunoadjuvants. Siedler F; Rudolph S; Musiol HJ; Moroder L Pept Res; 1992; 5(1):39-47. PubMed ID: 1623302 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs. Lefrancier P; Choay J; Derrien M; Lederman I Int J Pept Protein Res; 1977; 9(4):249-57. PubMed ID: 852928 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of conjugates between luteinizing hormone releasing hormone (LH-RH) and N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP) models of totally synthetic vaccines. Bernard JM; Gras-Masse H; Drobecq H; Tartar A; Lefrancier P; Hosmalin A; Carelli C; Chedid L Int J Pept Protein Res; 1987 Apr; 29(4):455-63. PubMed ID: 3298096 [TBL] [Abstract][Full Text] [Related]
32. Immunostimulatory activity of 1-O-acylated muramyl dipeptides, with or without a 6-O-phosphoryl group, in aqueous form. Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Nagamine T; Aizawa C; Mizunoe K; Kiso M; Hasegawa A; Nomoto K Int J Immunopharmacol; 1989; 11(1):35-43. PubMed ID: 2496044 [TBL] [Abstract][Full Text] [Related]
33. Syntheses of polymeric vesicles containing partial structures of N-acetyl-muramyl-dipeptide (MDP). Hönig H; Zenk R Chem Phys Lipids; 1990 Mar; 53(4):347-56. PubMed ID: 2340605 [TBL] [Abstract][Full Text] [Related]
34. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL). Phillips NC; Moras ML; Chedid L; Petit JF; Tenu JP; Lederer E; Bernard JM; Lefrancier P J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756 [TBL] [Abstract][Full Text] [Related]
35. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Kotani S; Tsujimoto M; Koga T; Nagao S; Tanaka A; Kawata S Fed Proc; 1986 Oct; 45(11):2534-40. PubMed ID: 3758371 [TBL] [Abstract][Full Text] [Related]
37. Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infection. Yapo A; Petit JF; Lederer E; Parant M; Parant F; Chedid L Int J Immunopharmacol; 1982; 4(3):143-9. PubMed ID: 7049971 [TBL] [Abstract][Full Text] [Related]
38. New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines. Lederer E Drugs Exp Clin Res; 1986; 12(6-7):429-40. PubMed ID: 3527628 [TBL] [Abstract][Full Text] [Related]
39. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide. Phillips NC; Rioux J; Tsao MS Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013 [TBL] [Abstract][Full Text] [Related]
40. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs. Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]